Sectors

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.

Japan Post Capital co-led a $13.8m round for the B2B subcontracting service that included Hakuhodo DY Ventures, Mitsubishi UFJ Capital, SBI Investment and UB Ventures.

The mobile app development platform is set to float on TSE’s Mothers Market in an initial public offering that would allow Globis, Itochu, Salesforce and Yahoo Japan to exit.

Q&A with Suzanna Chiu, head, Amadeus Ventures

CapitalG-backed short-term accommodation provider Airbnb last raised financing at a $1bn pre-money valuation in April.

Bertelsmann Asia Investments contributed to a round that the distributed database developer will use for global growth and research and development.

The mobile network operator has joined a pool of corporate investors in ride hailing service and strategic partner Gojek.

The food delivery platform developer, backed by Info Edge, Ant Financial, Uber and Delivery Hero, is now valued at $3.6bn.

Chronic illness drug developer Sigilon Therapeutics has filed to go public after raising almost $200m from investors including Eli Lilly.

Pfizer Ventures is the largest individual shareholder in the cancer therapeutics developer, which has filed for a $100m offering.